Hi
@StevieBuoyThis information straight from the lips of our CEO.
“We’ve got enough cash to get through the approval processes and then we’d have to tap the well again, but you’d be looking at a significantly bigger market cap as we continue to do as we raise capital, the market cap keeps getting much bigger. The next time we hit the well, we should be looking maybe at a
10 per cent raise against a far bigger number to get into commercial. Now, I know the big funds in our top four have supported us to say, “We will go all the way commercially…” and they’ll back us with that, so I’m not worried about scratching around for capital to start to raise the commercial profile of the company. ‘’
No need for others wild speculation of 40% dilution if we agree the next capital raise will come from the NASDAQ IPO duel listing.
With the above statement from our CEO in mind I would suggest US$50m will be the target amount to raise, obviously this would be a function of the share price at the time.
We are talking the same market cap with you suggesting possibly 20% dilution to achieve the US$100m, and he does say maybe a 10% raise.
WP to date has displayed a propensity to raise what is required verses the maximum he can, I don’t believe US$100m at that time will be required to go commercial.
I’m aware of some conjecture about the text verses the verbal interview, where 4th quarter may have been the nasdaq timeframe mentioned, to me that would be a better timeline as by then we will have 25-30 DurAVR implanted. The further we progress the higher the share price should be.
(20min delay)